However, in our study, MALAT1 gene expression varied by treatment, increasing in three combinations and significantly decreasing in four, notably with Ava and SAHA, underscoring the need for further research using primary GBM cultures to clarify its functional role. The gene discussed is MALAT1; the disease is glioblastoma.